Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs

D. Gibson*, I. Binyamin, M. Haj, I. Ringel, A. Ramu, J. Katzhendler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

A series of complexes PtAm2L [where Am2 = (NH3)2, ethylenediamine(en), 1,2-diaminocyclohexane (DACH) or (NH3)(c-C6H11NH2) and where L is a bidentate 1,1-dicarboxylate ligand tethered to 1- aminoanthraquinone by various spacers] was prepared and screened in vitro against P388 leukemia cells. The free ligands displayed moderate activity and the corresponding platinum complexes were tenfold more active. The nature of the linker chain does not seem to affect the potency of the complexes. The potency depends on the nature of the inert amine ligand [NH3 > DACH > en]. The low aqueous solubility of these complexes prevented any in vivo studies and the preparation of water soluble analogs is currently under way.

Original languageEnglish
Pages (from-to)823-831
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume32
Issue number10
DOIs
StatePublished - Oct 1997

Keywords

  • Anthraquinone
  • Anticancer
  • Carrier
  • Intercalator
  • Platinum

Fingerprint

Dive into the research topics of 'Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs'. Together they form a unique fingerprint.

Cite this